Shares of ValiRx plc (LON:VAL – Get Free Report) dropped 11.3% during mid-day trading on Friday . The company traded as low as GBX 0.77 ($0.01) and last traded at GBX 0.78 ($0.01). Approximately 6,817,075 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 27,612,842 shares. The stock had previously closed at GBX 0.88 ($0.01).
ValiRx Trading Up 5.7 %
The company has a debt-to-equity ratio of 0.49, a current ratio of 6.65 and a quick ratio of 1.27. The firm’s fifty day moving average price is GBX 1.08 and its 200-day moving average price is GBX 1.73. The company has a market cap of £1.22 million, a price-to-earnings ratio of -46.25 and a beta of 0.59.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- What Are Treasury Bonds?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Compound Interest and Why It Matters When Investing
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
